AR023757A1 - Procedimiento de racemizacion de fluoxetina quiral - Google Patents

Procedimiento de racemizacion de fluoxetina quiral

Info

Publication number
AR023757A1
AR023757A1 ARP000101919A ARP000101919A AR023757A1 AR 023757 A1 AR023757 A1 AR 023757A1 AR P000101919 A ARP000101919 A AR P000101919A AR P000101919 A ARP000101919 A AR P000101919A AR 023757 A1 AR023757 A1 AR 023757A1
Authority
AR
Argentina
Prior art keywords
fluoxetine
quiral
procedure
racemization
racemization procedure
Prior art date
Application number
ARP000101919A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of AR023757A1 publication Critical patent/AR023757A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/10—Separation; Purification; Stabilisation; Use of additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente se refiere a un procedimiento para epimerizar los isomeros de fluoxetina dando el racemato.
ARP000101919A 1999-04-26 2000-04-24 Procedimiento de racemizacion de fluoxetina quiral AR023757A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13107499P 1999-04-26 1999-04-26

Publications (1)

Publication Number Publication Date
AR023757A1 true AR023757A1 (es) 2002-09-04

Family

ID=22447749

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000101919A AR023757A1 (es) 1999-04-26 2000-04-24 Procedimiento de racemizacion de fluoxetina quiral

Country Status (4)

Country Link
AR (1) AR023757A1 (es)
AU (1) AU4010000A (es)
PE (1) PE20010067A1 (es)
WO (1) WO2000064855A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2313387T3 (es) 2004-06-28 2009-03-01 Teva Pharmaceutical Fine Chemicals S.R.L. Impureza de atomoxetina aislada, procedimiento para la preparacion de impurezas de atomoxetina y su utilizacion como patrones de referencia.
US7439399B2 (en) 2004-06-28 2008-10-21 Teva Pharmaceutical Fine Chemicals Processes for the preparation of atomoxetine hydrochloride
EP1768949A2 (en) 2004-07-22 2007-04-04 Teva Pharmaceutical Fine Chemicals S.R.L. Polymorphs of atomoxetiene hydrochloride
US7569729B2 (en) * 2005-04-05 2009-08-04 Teva Pharmaceutical Fine Chemicals S.R.L. Stable atomoxetine hydrochloride, a process for the preparation thereof, and an analytical control of its stability

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1283141B1 (it) * 1996-07-11 1998-04-07 Laporte Organics Francis S P A Procedimento per la preparazione di n-metil-3-(p-trifluorometilfenossi)-3-fenilpropilamina e dei suoi

Also Published As

Publication number Publication date
PE20010067A1 (es) 2001-02-02
AU4010000A (en) 2000-11-10
WO2000064855A1 (en) 2000-11-02

Similar Documents

Publication Publication Date Title
ECSP055953A (es) Granisetron transdermico
HN1999000015A (es) Tratamiento para una disfuncion sexual femenina
UY25242A1 (es) Inhibidores de benzotiazol de la proteína tirosina cinasa
AR025428A1 (es) Formas de administracion de tramadol retardadas mediante un revestimiento que contiene la sustancia activa tramadol en forma de sacarinato de tramadol asicomo eventualmente otros excipientes
HN1999000149A (es) Derivados de 4,4-biarilpiperidina
ECSP056020A (es) Inhibidores del factor inhibidor de la migración de los macrofagos y metodos para su identificacion
BR9904087B1 (pt) método para produzir uma lente de contato.
AR023757A1 (es) Procedimiento de racemizacion de fluoxetina quiral
HN1998000167A (es) Nuevo procedimiento para preparar una cetoimina
AR025351A1 (es) Agonistas retinoides selectivos par
UY26265A1 (es) Compuestos calciolíticos
HN1999000043A (es) Procedimiento para alquilar sulfonamidas impedidas estericamente.
BR9907417B1 (pt) método para produzir uma lente de contato.
ES1040982Y (es) Calzada fija para el trafico por ferrocarril.
ECSP003443A (es) Procedimiento de racemizacion de fluoxetina quiral
ES1054357Y (es) Base para el soporte de un grupo de bombeo.
AR018321A1 (es) Una forma de dosificacion de liberacion prolongada que comprende oxibutinina y los usos de la oxibutinina y de la forma de dosificacion de liberacionprolongada.
ES1041611Y (es) Suela perfeccionada para calzado.
ES2041120T3 (es) Un metodo para aplicar a una envoltura de quesos permanente asi como quesos asi obtenidos.
HN1999000128A (es) Nuevos usos farmaceuticos para inhibidores nos.
ES2167576T3 (es) Terpenos para la reduccion del efecto de feromonas sobre lepidopteros.
HN1998000062A (es) Pirozolopirimidonas para la disfucion sexual
ES1044138Y (es) Anillo para relacion sexual.
UY27824A1 (es) Nueva formulación para la administración parenteral de crobenetina.
HN1999000192A (es) Antagonistas de 54t1 para terapia antidepresiva